The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
sasha shulgin was interested in derivatives of amphetamines and he mdma was made you know back in 1904 as a possible agent for blood clotting but it never never got used and sheldon made it in the in the 60s and said wow this drug is different from amphetamines it's not activating it's not it's not driving me like amphetamines it's actually making it's giving me a clarity of thought but also a sense of warmness and empathy
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.